📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART) (2024)

First Author: Maitland K

Attributed to: Syndromic infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.20111.2

PubMed Identifier: 39219856

Publication URI: http://europepmc.org/abstract/MED/39219856

Type: Journal Article/Review

Parent Publication: Wellcome Open Research

ISSN: 2398-502X